OFI Invest Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
OFI Invest Asset Management's ALNY Position: Q2 2026 in Review
OFI Invest Asset Management increased its Alnylam Pharmaceuticals (ALNY) stake by 5,105% in Q2 2026, buying an estimated $11.2M and bringing the position to 37,945 shares worth $9.99M. The position accounts for 0.1% of the portfolio, ranked #134.
OFI Invest Asset Management first reported a position in ALNY in Q4 2023 and has held it in 8 quarters since. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- OFI Invest Asset Management held 37,945 shares of Alnylam Pharmaceuticals worth $9.99M as of Q2 2026.
- OFI Invest Asset Management bought 37,216 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $11.2M.
- Alnylam Pharmaceuticals made up 0.1% of OFI Invest Asset Management's portfolio in Q2 2026, its #134 holding.
- OFI Invest Asset Management first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
- 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.